Walleye Capital’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$304K Buy
10,300
+2,900
+39% +$74.5K ﹤0.01% 3165
2026
Q1
$173K Sell
7,400
-101,600
-93% -$1.84M ﹤0.01% 3420
2025
Q4
$1.55M Buy
109,000
+89,000
+445% +$1.68M ﹤0.01% 2072
2025
Q3
$495K Sell
20,000
-2,200
-10% -$49.1K ﹤0.01% 2615
2025
Q2
$504K Buy
22,200
+20,300
+1,068% +$481K ﹤0.01% 2631
2025
Q1
$57.6K Sell
1,900
-1,000
-34% -$38.1K ﹤0.01% 3807
2024
Q4
$115K Buy
+2,900
New +$131K ﹤0.01% 4070
2024
Q3
Sell
-4,500
Closed -$304K 5191
2024
Q2
$304K Buy
+4,500
New +$314K ﹤0.01% 3969
2019
Q4
Sell
-14,800
Closed -$460K 1727
2019
Q3
$460K Buy
+14,800
New +$451K 0.03% 799

Other funds holding ACHC

Walleye Capital's ACHC Position: Q2 2026 in Review

Walleye Capital reduced its Acadia Healthcare (ACHC) stake by 98% in Q2 2026, selling an estimated $2.76M and leaving 1,990 shares worth $58.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4125.

Walleye Capital first reported a position in ACHC in Q3 2019 and has held it in 13 quarters since. The position peaked at $26.7M in Q1 2025. 314 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • Walleye Capital held 1,990 shares of Acadia Healthcare worth $58.8K as of Q2 2026.
  • Walleye Capital sold 107,674 Acadia Healthcare shares in Q2 2026, an estimated $2.76M.
  • Acadia Healthcare made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4125 holding.
  • Walleye Capital first reported a position in Acadia Healthcare in Q3 2019 and has held it in 13 quarters since.
  • Walleye Capital's Acadia Healthcare position peaked at $26.7M in Q1 2025.
  • 314 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.